Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.

@article{Bashir2015RespiratoryMA,
  title={Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium.},
  author={Mustafa R. Bashir and Patricia K. Castelli and Matthew S Davenport and Douglas Larson and Daniele Marin and Hero K. Hussain and Tracy A. Jaffe},
  journal={Radiology},
  year={2015},
  volume={274 1},
  pages={141-8}
}
PURPOSE To determine, in a dual-center setting, whether patients who experience transient severe motion ( TSM transient severe motion ) in the arterial phase during gadoxetate disodium-enhanced magnetic resonance (MR) imaging are at higher risk for a subsequent episode of TSM transient severe motion than patients who do not have TSM transient severe motion during initial gadoxetate disodium administration. MATERIALS AND METHODS Institutional review board approval was obtained for this… CONTINUE READING